Physician profile

Thomas Lozowski

Family Medicine · Toms River, NJ

NPI 1104897354

$39,961.85

in general payments reported to CMS, 2019-2025

92 companies · $6,084 in 2025

The $6,084 reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$19,486.58
Education$307.51

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals LP $7,830.68 2019-2025 Fasenra, Farxiga, Tezspire
Abbvie INC. $3,198.67 2021-2025
Glaxosmithkline, LLC. $2,100.95 2019-2025 Trelegy Ellipta, Nucala, Shingrix
Abbott Laboratories $1,685.35 2019-2025 Freestyle Libre 3
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $1,545.56 2019-2025 Xifaxan, Trulance
Pfizer INC. $1,468.06 2019-2025
Lilly USA, LLC $1,260.29 2019-2025 Mounjaro, Zepbound, Jardiance
Novo Nordisk INC $1,091.45 2019-2025 Ozempic, Rybelsus, Wegovy
Bayer Healthcare Pharmaceuticals INC. $1,073.37 2021-2025
Regeneron Healthcare Solutions, INC. $898.84 2021-2025 Dupixent
Takeda Pharmaceuticals U.S.A., INC. $891.12 2019-2025 Trintellix
Amgen INC. $832.96 2019-2025 Repatha, Otezla, Otezla
Merck Sharp & Dohme LLC $797.68 2019-2025 Verquvo, Belsomra, Steglatro
Kowa Pharmaceuticals America, INC. $757.82 2019-2025 Zoryve, Seglentis, Livalo
Esperion Therapeutics, INC. $680.62 2020-2025 Nexletol
Show all 92 companies
CompanyGeneral paymentsYearsTop products
Mannkind Corporation $676.99 2019-2025 Afrezza
Allergan, INC. $646.99 2019-2020
Mylan Specialty L.P. $637.13 2019-2024 Yupelri
Sunovion Pharmaceuticals INC. $629.03 2019-2022
Janssen Pharmaceuticals, INC $621.92 2019-2024 Xarelto
Boehringer Ingelheim Pharmaceuticals, INC. $581.74 2020-2025 Jardiance
Corcept Therapeutics $560.15 2023-2025 Korlym
Philips North America LLC $538.44 2020-2025 (Ak6) Vest Therapy, Vest Therapy Und, (8874) Incourage
Sanofi-Aventis U.S. LLC $507.97 2019-2024
Antares Pharma, INC. $466.70 2020-2025 Xyosted
Axsome Therapeutics, INC. $441.62 2022-2025 Sunosi, Auvelity, Symbravo
Teva Pharmaceuticals USA, INC. $426.17 2019-2025 Austedo Xr, Austedo, Austedo Xr
Astellas Pharma US INC $419.90 2019-2025 Veozah, Myrbetriq
Scilex Pharmaceuticals INC. $411.37 2019-2025 Ztlido
Currax Pharmaceuticals LLC $333.58 2019-2025 Contrave, Onzetra Xsail, Nexlizet
Genzyme Corporation $307.06 2023-2025
Phathom Pharmaceuticals, INC. $305.31 2024-2025 Voquezna
Amarin Pharma, INC. $285.56 2019-2022
Otsuka America Pharmaceutical, INC. $278.94 2022-2025 Rexulti
Paratek Pharmaceuticals, INC. $270.29 2021-2025 Nuzyra, Xhance
Biohaven Pharmaceutical Holding Company LTD. $227.06 2022
Supernus Pharmaceuticals, INC. $219.32 2022-2023 Qelbree, Xyosted
Eisai INC. $218.94 2019-2022
Sumitomo Pharma America, INC. $210.71 2023-2025 Gemtesa
Nestle Healthcare Nutrition INC. $189.47 2021-2023
Horizon Therapeutics Plc $184.26 2019-2023 Krystexxa
Arbor Pharmaceuticals, INC. $178.21 2019-2022
Biohaven Pharmaceuticals, INC. $177.50 2020-2021
Exact Sciences Corporation $171.92 2023-2025 Cologuard Collection Kit
Tris Pharma INC $153.49 2023-2025 Dyanavel Xr
Dexcom, INC. $151.38 2021-2025 Dexcom G6 Transmitter
Tolmar, INC. $135.77 2023-2025 Jatenzo
Baxter Healthcare $133.91 2025
Aimmune Therapeutics, INC. $129.57 2024-2025 Zenpep
Jazz Pharmaceuticals INC. $114.44 2019-2022
Alk-Abello, INC $102.92 2019-2022
Fidia Pharma USA INC. $98.46 2019-2023 Hymovis, Triluron, Hyalgan
Almatica Pharma LLC $96.55 2023-2024 Teriparatide, Loreev Xr, Gralise
Daiichi Sankyo INC. $91.54 2022-2023 Injectafer
Intra-Sana Laboratories $85.09 2023-2024 Reltone 400 Mg, Glycate, Reltone 200 Mg
Genentech USA, INC. $83.90 2019-2021
Corium, LLC $82.53 2023-2025 Azstarys
Boston Scientific Corporation $80.28 2019-2025 Watchman Flx
Avanir Pharmaceuticals, INC. $72.44 2019-2021
Si-Bone, INC. $72.41 2019-2024
Topcon Healthcare Solutions, INC. $66.43 2020
Verity Pharmaceuticals INC. $63.44 2024-2025 Trelstar, Tlando
Aytu Biopharma, INC. $61.59 2019-2020
Xeris Pharmaceuticals, INC. $61.48 2022-2025 Recorlev, Gvoke Hypopen
Halozyme INC $58.41 2023
Soleno Therapeutics, INC. $56.97 2025 Vykat Xr
Biodelivery Sciences International, INC. $55.94 2021
Ibsa Pharma INC. $54.07 2025 Tirosint, Licart, Flector
Ironwood Pharmaceuticals, INC $52.28 2019-2020
Lundbeck LLC $50.89 2024-2025 Rexulti
Nalpropion Pharmaceuticals LLC $39.41 2019
Vanda Pharmaceuticals INC. $35.24 2025 Fanapt
Electromed, INC. $33.97 2024 Smartvest
Idorsia Pharmaceuticals US INC $31.42 2023 Quviviq
Vivus LLC $28.37 2019-2020
Melinta Therapeutics, LLC $28.06 2019
E.R. Squibb & Sons, L.L.C. $23.22 2020-2021
Radius Health, INC. $22.50 2020
Medicomp INC $18.57 2024 Telepatch Cardiac Monitor
Depuy Synthes Sales INC. $18.37 2020
Viatris Specialty LLC $17.97 2025 Yupelri
Bioventus LLC $17.63 2022
Medtronic, INC. $17.47 2025 Closurefast
Bausch Health US, LLC $16.11 2022
Hikma Pharmaceuticals USA $14.98 2019
Shionogi INC $14.70 2019
Azurity Pharmaceuticals, INC. $14.48 2023 Edarbi
Pacira Pharmaceuticals Incorporated $14.30 2024 Exparel, Zilretta, Iovera
Neurelis, INC. $14.08 2021
Watermark Medical, INC. $13.61 2025
Ucb, INC. $12.36 2022
Acorda Therapeutics, INC $11.18 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Thomas Lozowski

$39,961.85

in general payments reported 2019-2025

Years
2019-2025
Top company
Astrazeneca Pharmaceuticals LP
Context
The $6,084 reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).

https://glasscript.com/doctor/94938/thomas-lozowski

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.